By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Glaukos Corporation 

26061 Merit Circle
Suite 101
Laguna Hills  California  92653  U.S.A.
Phone: 949-367-9600 Fax:



Start Up

Company News
Preeminent Ophthalmologist, L. Jay Katz Joins Glaukos As Chief Medical Officer 2/22/2017 6:35:35 AM
Glaukos Completes Patient Enrollment In Pivotal Phase Of U.S. IDE Clinical Trial For iStent SUPRA 2/16/2017 6:28:28 AM
Glaukos To Release Fourth Quarter And Full Year 2016 Financial Results After Market Close On March 1 2/8/2017 9:26:38 AM
Joseph Gilliam To Join Glaukos As Chief Financial Officer And Senior Vice President Of Corporate Development 2/6/2017 6:38:00 AM
Glaukos Promotes Chris M. Calcaterra To Chief Operating Officer 2/2/2017 8:54:35 AM
Study Published In Journal Of Glaucoma Evaluates A Single Glaukos iStent Trabecular Micro-Bypass Stent As A Standalone Procedure 12/12/2016 10:35:06 AM
Glaukos Announces Third Quarter 2016 Financial Results 11/11/2016 12:53:17 PM
Glaukos Completes Patient Enrollment In Initial Phase Of U.S. IDE Clinical Trial For Standalone Version Of Istent Inject 11/10/2016 2:37:55 PM
New International Study Highlights IOP-Lowering Performance Of Glaukos iStent Inject Trabecular Micro-Bypass In Standalone Procedure 11/8/2016 10:35:49 AM
Glaukos Release: iStent Trabecular Micro-Bypass Stent Reduced IOP And Medication Use In Predominately Hispanic Glaucoma Patient Population, According To Published Study 10/31/2016 11:40:21 AM